Back

Cardiovascular events risk in office-masked nocturnal hypertension defined by home blood pressure monitoring: the J-HOP nocturnal blood pressure study

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Hypertension phenotypes Blood Pressure Measurement ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Takeshi Fujiwara

Jichi Medical University, Shimotsuke (Japan)

6 More presentations in this session

Presentation thumbnail
Association of cardio-cerebrovascular death with isolated diastolic hypertension: a nationally representative survey of 85, 138 adults
Professor Y. Zhang (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
Association of different timepoint and threshold of time-in-target-range and MACEs: insight from the SPRINT study
Professor Y. Zhang (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
Masked hypertension is highly prevalent among patients with high-normal office blood pressure - based on the results of the Hungarian ABPM Registry
Doctor D. Pasztor (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
Office, home and 24h ambulatory blood pressure monitoring in preeclampsia and uncomplicated hypertension in pregnancy
Slides Video
Presentation thumbnail
Invasive validation of central blood pressure measurements using a suprasystolic monitor
Professor S. Carlier (Mons, BE)
Abstract Slides Video

Access the full session

Session thumbnail
Hypertension phenotypes

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Association between nocturnal hypertension and composite cardiovascular outcomes in the extremely elderly population aged over 80 years
thumbnail
Congress Presentation
Home blood pressure control status altered the cardiovascular prognosis associated with left ventricular hypertrophy in a Japanese nationwide general practice population: The J-HOP Study
thumbnail
Congress Presentation
Differential impact of clinic BP target on the prevalence and predictors of the masked uncontrolled hypertension and white-coat uncontrolled hypertension

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources